Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 19.35
-0.45 (-2.27%)
At close: Apr 23, 2026
Daiken Biomedical Revenue
In the year 2025, Daiken Biomedical had annual revenue of 1.90B TWD with 39.10% growth. Daiken Biomedical had revenue of 656.11M in the quarter ending December 31, 2025, with 20.63% growth.
Revenue
1.90B
Revenue Growth
+39.10%
P/S Ratio
8.06
Revenue / Employee
n/a
Employees
20
Market Cap
15.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.90B | 532.70M | 39.10% |
| Dec 31, 2024 | 1.36B | 171.97M | 14.45% |
| Dec 31, 2023 | 1.19B | 305.45M | 34.52% |
| Dec 31, 2022 | 884.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition